Recombinant CD19 (Tafasitamab Biosimilar) 抗体
This anti-CD19 (Tafasitamab Biosimilar) antibody is a Humanized Chimeric antibody detecting CD19 (Tafasitamab Biosimilar) in not_set. Suitable for 人.
产品编号 ABIN7598017
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Recombinant CD19 (Tafasitamab Biosimilar) 抗体 (ABIN7598017)
抗原
CD19 (Tafasitamab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Humanized
克隆类型
Chimeric
标记
This CD19 (Tafasitamab Biosimilar) antibody is un-conjugated
应用范围
请咨询
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Research Grade Tafasitamab Biosimilar Antibody
-
特异性
- CD19, Differentiation antigen CD19, T-cell surface antigen Leu-12, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4
-
纯化方法
- Protein A or G purified from cell culture supernatant.
-
纯度
- >95 % by SDS-PAGE.
-
亚型
- IgG1 IgG2 mix
-
-
-
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 6.03 mg/mL
-
缓冲液
- 0.01M PBS, pH 7.4.
-
储存条件
- 4 °C,-20 °C,-80 °C
-
储存方法
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
有效期
- 12 months
-
-
- CD19 (Tafasitamab Biosimilar)
-
别名
- Tafasitamab Biosimilar
-
物质类
- Biosimilar
-
背景
- CD19, Differentiation antigen CD19, T-cell surface antigen Leu-12, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4
-
UniProt
- P15391
-
CAS-编号
- 1422527-84-1
抗原
-
You are here:
